1
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed and Berry, March 23, 1999: US05886026 (291 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


2
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group PLLC, April 8, 2003: US06544544 (182 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


3
William L Hunter, Lindsay S Machan: Compositions and methods for treating or preventing diseases of body passageways. Angiotech Pharmaceuticals, The University of British Columbia, Seed Intellectual Property Law Group PLLC, July 6, 2004: US06759431 (117 worldwide citation)

The present invention provides methods for treating or preventing diseases associated with body passageways, comprising the step of delivering to an external portion of the body passageway a therapeutic agent. Representative examples of therapeutic agents include anti-angiogenic factors, anti-prolif ...


4
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, SEED Intellectual Property Law Group PLLC, January 14, 2003: US06506411 (95 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also, provided are methods for embolizing blood vessels, ...


5
William L Hunter: Compositions and methods for treating surgical adhesions. Angiotech Pharmaceuticals, Seed IP Law Group PLLC, February 10, 2004: US06689803 (94 worldwide citation)

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.


6
Brian G Amsden, Richard T Liggins: Methods for microsphere production. Angiotech Pharmaceuticals, Seed Intellectual Property Law Group PLLC, May 1, 2001: US06224794 (75 worldwide citation)

A process for forming microspheres that includes passing a first composition containing polymer and solvent through an orifice and directly into a second composition containing water and a microsphere-stabilizing agent, under at least one of conditions (a) and (b), wherein (a) the first composition ...


7
William L Hunter, Lindsay S Machan, A Larry Arsenault: Anti-angiogenic compositions and methods of use. Angiotech Pharmaceuticals, Seed IP Law Group PLLC, January 25, 2005: US06846841 (63 worldwide citation)

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, ...


8
William L Hunter: Composition and methods of paclitaxel for treating psoriasis. Angiotech Pharmaceuticals, Seed IP Law Group PLLC, February 4, 2003: US06515016 (45 worldwide citation)

The present invention provides methods for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.


9
William L Hunter, Keith L March: Intrapericardial delivery of anti-microtubule agents. Angiotech Pharmaceuticals & Advanced Research Tech, Seed IP Law Group, December 25, 2001: US06333347 (36 worldwide citation)

Methods and compositions are provided for intra-pericardial administration of anti-microtubule agents, suitable for use in treating or preventing a variety of diseases of the pericardium, heart, or, coronary vasculature.


10
Alexei Goraltchouk, Alexander Naimagon, Gerald F Cummings, Lev Drubetsky, Robert A Herrmann: Composite self-retaining sutures and method. Angiotech Pharmaceuticals, February 21, 2012: US08118834 (34 worldwide citation)

A self-retaining suture comprises a composite filament. The filament has retainers on the surface such that the filament can engage and retain tissue without knots. The filament comprises at least two materials having different properties. A surface material of the filament has properties which enha ...



Click the thumbnails below to visualize the patent trend.